Overview / Abstract: |
Target Audience This online educational activity is directed toward ophthalmologists, optometrists and other healthcare professionals who would be involved in dry eye disease care, such as PCPs, NPs and PAs. Program Overview This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of meibomian gland dysfunction (MGD)-associated dry eye disease (DED), with a forward-looking perspective on how new and novel agents may impact clinical practice. An overview of MGD and its association with DED as well as current and emerging treatment strategies will be presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements. Learning Objectives Upon completion of this activity, participants should be better able to: Discuss the impact that MGD-associated DED has on patients’ QoL |
Expiration |
Nov 30, 2022 |
Discipline(s) |
Nursing CNE, Optometry / Ophthalmology CE, Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
Bausch + Lomb |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Meibomian Gland Dysfunction Free CE CME |